Latest News & Features
Europe
A European court dismissed a challenge by a German generics manufacturer, confirming the validity of a patent covering a blood cancer combination therapy. 28 May 2026
Americas
Choosing between patent protection and trade secrets is a delicate balancing act, especially amid regulatory scrutiny and unpredictable patent office timelines. This session delves into the frontlines of IP strategy, offering practical guidance on when each protection mechanism serves best. 28 May 2026
Asia
China’s IP system is undergoing real change. Takeda’s IP head for the region explains what that looks like on the ground and why the old playbook no longer cuts it. 27 May 2026
Careers
A senior pharmaceutical lawyer, with experience across private practice and Big Pharma, joins the company after a decade-long tenure at Teva. 27 May 2026
Americas
Structuring successful IP transactions in the life sciences sector requires rigorous due diligence and sophisticated valuation models. This panel brings together deal-makers and valuation experts to share strategies for protecting value and enabling innovation in complex M&A and licensing deals. 27 May 2026
Americas
Two days of discussions at LSPN North America revealed an industry grappling with narrower patent claims, global strategy changes, AI disruption and tougher dealmaking conditions. 26 May 2026
Careers
In the first of a series of interviews with women UPC judges, Ingeborg Simonsson talks to Sarah Speight about her career highs and lows, including defying expectations of women in the profession and why having a clear goal is key. 26 May 2026
Americas
Ahead of WIPR Trade Secrets West, Cooley partner Heidi Keefe says that for legal teams, caution—not business pressure—should be the priority. 26 May 2026
Europe
The EPO's approach to claim interpretation has shifted significantly following the G1/24 decision. This session unpacks how Technical Boards of Appeal are newly applying the mandate to consult descriptions and drawings, and what this means for drafting and opposition strategy. 26 May 2026
Americas
What is the most effective way to allocate patent activities between in-house teams and external counsel? This panel explores strategies for maximising ROI, controlling costs, and fostering seamless collaboration across internal scientists, legal teams, and service providers. 25 May 2026